What is the primary treatment modality for vasomotor rhinitis?

The primary treatment modality for vasomotor rhinitis is intranasal steroids. Vasomotor rhinitis is characterized by nasal symptoms such as congestion, runny nose, and sneezing, which are triggered by non-allergic factors like changes in weather, strong odors, or stress.

Intranasal steroids are effective because they reduce inflammation within the nasal passages, thereby alleviating symptoms associated with vasomotor rhinitis. They work by targeting the underlying inflammatory processes rather than just addressing symptoms, which makes them particularly beneficial for this condition.

Other treatment options, while they may occasionally relieve symptoms, are not considered first-line therapies. For example, oral steroids may be used in more severe or specific cases but come with a higher risk of systemic side effects, making them less desirable for a chronic condition like vasomotor rhinitis. Systemic antihistamines primarily target allergic responses and may not be effective for non-allergic triggers. Nasal decongestants can provide temporary relief from congestion but are not intended for long-term management and can lead to rebound congestion if overused. Thus, intranasal steroids are favored for their targeted, lasting therapeutic effects in managing vasomotor rhinitis.